Aspect Partners LLC Raises Holdings in Core Scientific, Inc. (NASDAQ:CORZ)

Aspect Partners LLC raised its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 328.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 35,678 shares of the company’s stock after acquiring an additional 27,360 shares during the quarter. Aspect Partners LLC’s holdings in Core Scientific were worth $423,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. P Schoenfeld Asset Management LP acquired a new stake in Core Scientific in the second quarter valued at approximately $4,185,000. Vanguard Group Inc. purchased a new position in shares of Core Scientific during the 1st quarter valued at approximately $21,973,000. Hexagon Capital Partners LLC acquired a new stake in Core Scientific in the 1st quarter valued at $34,000. Blair William & Co. IL purchased a new stake in Core Scientific in the 1st quarter worth $1,156,000. Finally, DeepCurrents Investment Group LLC raised its position in Core Scientific by 157.7% during the second quarter. DeepCurrents Investment Group LLC now owns 255,162 shares of the company’s stock worth $2,373,000 after acquiring an additional 156,162 shares during the period.

Insider Buying and Selling

In other Core Scientific news, insider Todd M. Duchene sold 11,582 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $9.41, for a total value of $108,986.62. Following the sale, the insider now owns 1,686,474 shares of the company’s stock, valued at $15,869,720.34. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, insider Todd M. Duchene sold 11,582 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $9.41, for a total transaction of $108,986.62. Following the transaction, the insider now owns 1,686,474 shares of the company’s stock, valued at approximately $15,869,720.34. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Denise Marie Brucia Sterling sold 8,752 shares of Core Scientific stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the completion of the transaction, the chief financial officer now directly owns 122,217 shares of the company’s stock, valued at approximately $1,150,061.97. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders purchased 12,761 shares of company stock valued at $127,080. Company insiders own 32.00% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on CORZ. BTIG Research lifted their target price on shares of Core Scientific from $10.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday, June 26th. Canaccord Genuity Group began coverage on Core Scientific in a report on Monday, September 23rd. They set a “buy” rating and a $16.00 target price for the company. LADENBURG THALM/SH SH reaffirmed a “buy” rating and issued a $14.50 price target on shares of Core Scientific in a research note on Tuesday, July 2nd. HC Wainwright raised their price objective on Core Scientific from $11.00 to $15.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and set a $16.00 target price on shares of Core Scientific in a research note on Friday. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $15.27.

Core Scientific Trading Up 0.5 %

Core Scientific stock traded up $0.06 during mid-day trading on Tuesday, hitting $13.03. The company’s stock had a trading volume of 6,103,596 shares, compared to its average volume of 8,567,853. Core Scientific, Inc. has a 1 year low of $2.61 and a 1 year high of $13.42. The stock’s fifty day moving average is $10.90 and its two-hundred day moving average is $8.07.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($4.51) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($4.47). The company had revenue of $141.10 million during the quarter, compared to analysts’ expectations of $128.58 million. Core Scientific’s quarterly revenue was up 11.2% compared to the same quarter last year. As a group, research analysts predict that Core Scientific, Inc. will post 0.01 earnings per share for the current year.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.